Raptor Pharmaceutical Corp.
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Raptor Pharmaceutical Corp.
Inaugural artificial intelligence recommendations from NICE on radiotherapy contouring should allow clinicians to spend more time with patients and on complex cases where AI is not an option. But large language models are not appropriate in all cases, cautions Adrian Sutherland, principal healthcare architect at Endava consultancy.
In this video interview, Novo Holdings’ Noel Jee shares his views on the Korean biotech industry and innovation, including how to draw more foreign investment into the sector.
More sponsors are submitting applications around the same time requiring the agency to make complicated decisions about exclusivity and whether approval of subsequent applications is barred, FDA attorney says.
- Site Specific
- Drug Delivery
- Large Molecule
- Other Names / Subsidiaries
- Encode Pharmaceuticals, Inc.
- TorreyPines Therapeutics, Inc. (Neurogenetics Inc.)
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.